Latest Budesonide Stories
Serious adverse reactions, including psychiatric, respiratory, thoracic, mediastinal, skin, and subcutaneous disorders, and death were reported in association with use of asthma medications in
SAN DIEGO, Sept. 25, 2014 /PRNewswire/ -- Meritage Pharma, Inc.
LifeScienceIndustryResearch.com adds “Symbicort (Asthma) - Forecast and Market Analysis to 2023” to its store.
DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/s3kv36/investigation) has announced the addition of the "Investigation
PITTSBURGH, June 23, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that the U.S. District Court for the District of Delaware has found after trial that Mylan subsidiary Mylan Pharmaceuticals Inc. does not infringe the asserted claims of U.S. Patent No.
CHICAGO, May 10, 2011 /PRNewswire/ -- Meritage Pharma, Inc.
SAN DIEGO, March 1, 2011 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today highlighted its financial results and product development progress for the year ended December 31, 2010. "Prometheus had another record year in 2010, our 14th consecutive year of sales growth," said Joseph M.
- totally perplexed and mixed up.